Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

24.00
+1.305.73%
Pre-market: 24.190.1900+0.79%05:05 EDT
Volume:4.66M
Turnover:112.41M
Market Cap:4.06B
PE:-28.57
High:25.52
Open:22.99
Low:22.63
Close:22.70
52wk High:34.39
52wk Low:6.32
Shares:169.00M
Float Shares:142.96M
Volume Ratio:2.68
T/O Rate:3.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8400
EPS(LYR):-0.8746
ROE:-21.34%
ROA:-12.99%
PB:3.96
PE(LYR):-27.44

Loading ...

Tango Therapeutics - to Advance Vopimetostat Plus Daraxonrasib Into Phase 3 for Mtap-Deleted Pancreatic Cancer

THOMSON REUTERS
·
Jun 08

A Look At Tango Therapeutics (TNGX) Valuation As Optimism Builds Around Upcoming Pancreatic Cancer Data

Simply Wall St.
·
Jun 07

Tango Therapeutics grants new hire 170,000-share stock option at $23.1, awards 40,000 RSUs

Reuters
·
Jun 05

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 05

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05

Tango Therapeutics shareholders elected two Class II directors at annual meeting

Reuters
·
Jun 05

Tango Therapeutics President, R&D Crystal Adam disposes of USD 618,289 in common shares

Reuters
·
Jun 04

Stifel Nicolaus Sticks to Its Buy Rating for Tango Therapeutics (TNGX)

TIPRANKS
·
May 18

Assessing Tango Therapeutics (TNGX) Valuation After Trial Progress And Leadership Changes

Simply Wall St.
·
May 16

Tango Therapeutics falls -14.9%

TIPRANKS
·
May 15

Stock Track | Tango Therapeutics Plummets 10.11% Intraday Following Analyst Rating Downgrade

Stock Track
·
May 15

Tango Therapeutics Inc : Mizuho Raises Target Price to $30 From $20

THOMSON REUTERS
·
May 15

Stock Track | Tango Therapeutics Plunges 9.73% in Pre-Market on Analyst Downgrades

Stock Track
·
May 15

U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

Reuters
·
May 15

Stock Track | Tango Therapeutics Plummets 10.82% Intraday Following Jefferies Downgrade to Hold

Stock Track
·
May 15

Stock Track | Tango Therapeutics Plunges 6.7% in Pre-market Following Jefferies Downgrade to Hold

Stock Track
·
May 14

Stifel Nicolaus Sticks to Their Buy Rating for Tango Therapeutics (TNGX)

TIPRANKS
·
May 14

Tango Therapeutics Inc : Jefferies Cuts to Hold From Buy; Raises Target Price to $27 From $18

THOMSON REUTERS
·
May 14

Tango Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 14

Tango Therapeutics Q1 FY26 net loss widens to $45.51 million

Reuters
·
May 14